Aurora Cannabis and its wholly-owned subsidiary CanniMed Therapeutics have added product information numbers (PINs) to 78 medical cannabis products so to better facilitate and track insurance coverage for their Canadian patients. The products that received PINs include dried flower, capsules, soft gels, topicals and oils.
"PINs help employers and insurance companies classify and incorporate health care products into benefit coverage plans", the company explains. "Patients submitting claims to their third-party insurer can now identify specific products and thereby speed up the adjudication and medical coverage process. MedReleaf, another wholly-owned subsidiary of Aurora, introduced PINs to 57 medical cannabis products in 2018."
“This is great news for insurance companies, employers and most importantly our patients,” says Aurora CEO Terry Booth. “Introducing PINs for medical cannabis products will make the claims process more seamless, enabling insurance companies to add these products to their formularies while providing patients and employers with a simplified process to complete claims. It’s another step toward enhancing patient access, something Aurora cares deeply about.”
For more information:
P.O. Box 209
Cremona, AB. T0M0R0